Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-285567

Chief Legal Officer sold 13,008 shares at $45.03 ($585,750)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-25 Sale : show line 1 in the form 10b5-1 −13,008 $45.03 $585,750 320,571 D
Open-market sales · 13,008 sh · avg $45.03 · $585,750
Loading xslF345X06/ownership.xml…